Related Experiment Video
Updated: Dec 11, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
[Effect of Regulating A20 Expression on NF-κB Expression and Biological Characteristics of Jurkat Cells]
Zhe Wang1, Shi-Shan Xiao1, Qian Ding1
1Department of Hematology, Guizhou Provincial People's Hospital, Guiyang 550002, Guizhou Province, China.
Objective:
To explore the effect of regulating A20 expression on NF-κB and biological characteristics of Jurkat cells with glucocorticoid (GC) resistance.
Methods:
CCRF CEM and Jurkat cells were treated with dexamethasone (DEX) at concentrations of 100、10、1、0.1、0.01 and 0.001 μmol/L, and cultured for 24、48 and 72 h. The proliferation inhibition rate of Jurkat cell was detected by CCK-8. A20 plasmid was constructed, A20-siRNA was designed and synthesized, and transfected into Jurkat cells by liposome. CCK-8 was used to detect the proliferation rates of Jurkat cells in different concentrations of DEX group, DEX combined with A20 plasmid group and A20-siRNA group. The mRNA expression level of NF-κB was detected by RT-qPCR, the protein expression level of NF-κB was detected by Western blot, and the apoptosis of Jurkat cells was examined by flow cytometry.
Results:
The inhibitory effects of DEX at different concentrations on the growth of CCRF CEM cells were time-dependent (r=0.984, P<0.05) and concentration-dependent (r=0.966, P<0.05). At the point of 24 hour, the IC50 approached 1 μmol/L in CCRF CEM cells. Great large differences began to appear between 1 and 10 μmol/L, the proliferation rate of Jurkat cells treated with 1 μmol/L DEX did not show a significant change. Therefore, 1 μmol/L was selected as control group. The cell proliferation rate of A20 plasmid transfection combined with different concentrations of DEX group was lower than that of DEX group and A20-siRNA combined with DEX group. After transfection of A20 plasmid, the expression level of NF-κB was significantly lower than that of control group (P<0.05), and the apoptotic rate was significantly higher than that of control group (P<0.05). After transfection of Jurkat cells with A20-siRNA, the expression level of NF-κB was significantly higher than that of control group (P<0.05). The apoptotic rate of cells in A20-siRNA group was not significantly changed (P>0.05).
Conclusion:
Jurkat cells are resistant to DEX. A20 overexpression combined with DEX can increase sensitivity of Jurkat cells with GC resistance and decrease the proliferation rate of Jurkat cells, down-regulate the expression level of NF-κB and promote the apoptosis of Jurkat cells.
Insights
Overexpressing A20 enhances glucocorticoid (GC) sensitivity in resistant Jurkat cells. This approach reduces cell proliferation, lowers NF-κB expression, and promotes apoptosis, offering a potential therapeutic strategy.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Glucocorticoid (GC) resistance is a significant challenge in treating certain leukemias, necessitating novel therapeutic strategies.
- The NF-κB signaling pathway plays a crucial role in cell survival and resistance to apoptosis, often implicated in GC resistance.
- A20 is a key negative regulator of NF-κB signaling, suggesting its potential role in modulating GC sensitivity.
Purpose of the Study:
- To investigate the impact of regulating A20 expression on the biological characteristics of Jurkat cells exhibiting glucocorticoid resistance.
- To determine the effect of A20 modulation on NF-κB signaling pathway activation in these resistant cells.
Main Methods:
- Jurkat and CCRF CEM cells were exposed to varying concentrations of dexamethasone (DEX) over different time points.
- Cell proliferation was assessed using the CCK-8 assay.
- A20 expression was manipulated by transfecting cells with an A20 plasmid (overexpression) or A20-siRNA (knockdown).
- NF-κB mRNA and protein levels were quantified using RT-qPCR and Western blot, respectively.
- Apoptosis was analyzed by flow cytometry.
Main Results:
- Dexamethasone exhibited time- and concentration-dependent inhibition of CCRF CEM cell growth, with an IC50 around 1 μmol/L at 24 hours.
- Jurkat cells demonstrated resistance to DEX at 1 μmol/L.
- Overexpression of A20 in Jurkat cells, in combination with DEX, significantly reduced cell proliferation compared to DEX alone or A20-siRNA treatment.
- A20 overexpression led to a significant decrease in NF-κB expression and a significant increase in apoptosis.
- A20-siRNA treatment resulted in a significant increase in NF-κB expression without significantly altering apoptosis.
Conclusions:
- Jurkat cells exhibit resistance to dexamethasone.
- A20 overexpression, coupled with DEX, enhances the sensitivity of GC-resistant Jurkat cells.
- This combined approach effectively reduces cell proliferation, downregulates NF-κB expression, and promotes apoptosis in Jurkat cells.
More Related Videos
04:47A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Co-activators and Co-repressors
The JAK-STAT Signaling Pathway
Regulation of Nuclear Protein Sorting
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...